Abstract: An ultra-wideband electromagnetic band gap (EBG) structure includes multiple EBG units in an array. Each EBG unit includes a power plane, a dielectric substrate and a ground plane from top to bottom. The power plane includes a patch, a coupled complementary split ring resonator (C-CSRR) and a plurality of semi-improved Z-bridge structures. Each edge of the patch is provided with a semi-improved Z-bridge structure. The C-CSRR is provided within a ring formed by the semi-improved Z-bridge structures. The Z-bridge structure includes a first horizontal branch, a first vertical branch, a second horizontal branch and a second vertical branch connected in sequence. The second vertical branch is connected to the patch. First horizontal branches of adjacent EBG units are connected to each other. A circuit board including the aforementioned EBG structure is also provided.

Abstract: Provided is a photovoltaic module, including a first intermediate busbar having a first lead-out terminal provided at an end thereof; a second intermediate busbar having a second lead-out terminal provided at an end thereof; and a first jumper wire arranged on a first isolation bar; the first lead-out terminal and the second lead-out terminal are located on two opposite sides of the first jumper wire, and the first lead-out terminal and the second lead-out terminal abut against two opposite side surfaces of the first isolation bar or overlap a top surface of the first isolation bar. Compared with the related art, the first isolation bar where the first jumper wire is located is clamped or pressed by the first lead-out terminal and the second lead-out terminal, to prevent short circuit or shielding of the cell caused by free movement of the first jumper wire, the first and second intermediate busbars.

Abstract: A broadband fifth-generation (5G) circularly polarized filtering antenna includes a reflecting plate, a first dielectric substrate, a second dielectric substrate, a third dielectric substrate, a fourth dielectric substrate, a feed line with a phase adjustment function print on one surface of the first dielectric substrate, a ground with a chair-like groove on an other surface of the first dielectric substrate, a first rectangular radiating unit, a second rectangular radiating unit, a first metal transmission strip group and a second metal transmission strip group.

Abstract: A broadband fifth-generation (5G) circularly polarized filtering antenna includes a reflecting plate, a first dielectric substrate, a second dielectric substrate, a third dielectric substrate, a fourth dielectric substrate, a feed line with a phase adjustment function print on one surface of the first dielectric substrate, a ground with a chair-like groove on an other surface of the first dielectric substrate, a first rectangular radiating unit, a second rectangular radiating unit, a first metal transmission strip group and a second metal transmission strip group.

Abstract: The present invention relates to a class of TrkA inhibitors and an application thereof in the preparation of a drug for the treatment of diseases associated with TrkA. The present invention specifically discloses compounds represented by formula (I) and formula (II), tautomer thereof or pharmaceutically acceptable salts thereof.

Abstract: For the problem of difficult roof anchor withdrawal at the end of a working face, a static crushing directional anchor withdrawal method at the end of a large-mining-height working face is provided. The method includes the following steps: designing key parameters of boreholes for static crushing, including a borehole position, a spacing between boreholes, a borehole depth, and a borehole diameter at the end of a working face; then determining parameters of a static crushing agent grouting technology device for the construction of a static crushing process; and carrying out an anchor withdrawal operation at the end.

Abstract: A class of lactam-modified polypeptide compounds and the use thereof in the preparation of a drug for treating related diseases.

Abstract: An amorphous form of dezocine analogue hydrochloride is represented by formula (II). An X-ray powder diffraction spectrum of the amorphous form is shown in FIG. 1.

Abstract: A three-dimensional structured multi-level interlocking structure and a preparation method thereof, the multi-level interlocking structure comprises: a first interlocking structure comprising a first bonding component, first bonding troughs and first macrostmctures alternately positioned on the surface of the first bonding component, and a second interlocking structure comprising a second bonding component, second bonding troughs and second macrostmctures alternately positioned on the surface of the second bonding component, the first macrostructures are aligned with the second bonding trough, and the second macrostmctures are aligned with the first bonding trough; and the first macrostructure has a first end away from the first bonding component and the second macrostructure has a first end away from the second bonding component, the first ends of the first macrostructure and the second macrostructure comprise a top plane, the first end of the first macrostructure extends past the top plane of the second mac

Abstract: Disclosed in the present invention are a crystal form of a TrkA inhibitor and a preparation method thereof, and an application thereof in preparation of drugs for treating diseases associated with pain, cancer, inflammation, neurodegenerative diseases, and certain infectious diseases.

Abstract: Disclosed is a method for preparing a pyrrolidinyl urea derivative, which acts as a TrkA inhibitor, and further disclosed are an intermediate compound of a compound of formula (I) and a preparation method therefor.

Abstract: The use of a phenylpropionamide compound in the preparation of a drug for treating diseases associated with pain and pruritus. Specifically, the present invention relates to a compound as represented by formula (I) or a pharmaceutically acceptable salt thereof.

Abstract: Disclosed in the present invention are a crystal form of a TrkA inhibitor and a preparation method therefor, and an application thereof in preparation of drugs for treating diseases associated with pain, cancer, inflammation, neurodegenerative diseases, and certain infectious diseases.

Abstract: Disclosed is a method for preparing a pyrrolidinyl urea derivative, which acts as a TrkA inhibitor, and further disclosed are an intermediate compound of a compound of formula (I) and a preparation method therefor.

Abstract: The present invention relates to a crystal form and an amorphous form of dezocine analogue hydrochloride, and in particularly, to a crystal form of a compound represented by formula (I) and an amorphous form of a compound represented by formula (II). An X-ray powder diffraction spectrum of the crystal form comprises characteristic peaks at 20 values of 13.1°±0.2°, 16.8±0.2°, and 18.5±0.2°, and an X-ray powder diffraction spectrum of the amorphous form is shown in FIG. 1.

Abstract: The present invention relates to a crystal form and an amorphous form of dezocine analogue hydrochloride, and in particularly, to a crystal form of a compound represented by formula (I) and an amorphous form of a compound represented by formula (II). An X-ray powder diffraction spectrum of the crystal form comprises characteristic peaks at 2? values of 13.1°±0.2°, 16.8±0.2°, and 18.5±0.2°, and an X-ray powder diffraction spectrum of the amorphous form is shown in FIG. 1.

Abstract: The present disclosure relates to a data processing method, which includes: selection controls of at least two different measurement units are displayed; a calculation parameter is acquired; a measurement unit of the calculation parameter is determined according to a selection operation executed on a selection control; and measurement unit unification is performed on at least two calculation parameters of different measurement units to obtain a calculation result of the calculation parameters.

Abstract: Disclosed are an angiotensin II receptor 2 (AT2R) antagonist salt form and crystalline form, a preparation method therefor, and an application of the salt form and crystalline form in preparing a drug which treats chronic pain.

Abstract: The present disclosure relates to the technical field of non-destructive detecting of residual stress, and in particular to a non-destructive detecting device for component residual stress gradient.

Abstract: The present invention relates to a series of 2,6-dioxaspiro [4,5] decane derivatives and applications thereof in preparation of opiate receptor ? agonist related drugs; and in particular relates to the derivative compounds shown in formula (I), tautomers thereof or pharmaceutically acceptable compositions thereof.